Literature DB >> 30908942

B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulin A production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis.

Giuliana Medrano1, Frederic Cailleux1, Peihong Guan1, Korah Kuruvilla1, Amanda J Barlow-Anacker2, Ankush Gosain1,3.   

Abstract

Hirschsprung disease (HSCR) is a common cause of intestinal obstruction in the newborn. Hirschsprung-associated enterocolitis (HAEC) is a significant and life-threatening complication of HSCR, affecting up to 60% of patients. Animal models of endothelin receptor B (EdnrB) mutation reliably model human HSCR and HAEC. We previously demonstrated intestinal dysbiosis and a gut-specific deficiency of B-lymphocyte-produced secretory IgA (sIgA), the primary effector molecule of mucosal immunity, in mice with homozygous neural crest cell-conditional deletion of EdnrB (EdnrBNCC-/-). To determine mechanisms for sIgA deficiency, we examined intrinsic and extrinsic aspects of B-lymphocyte development and function. Expression of the endothelin axis components [endothelin-1 (ET-1), endothelin-3 (ET-3), endothelin receptor A (EdnrA), EdnrB] were determined over a developmental time course. B-lymphocyte survival and Ig production were assayed in vitro. Polymeric Ig receptor (pIgR)-mediated IgA transport into the intestinal lumen was interrogated. We found endothelin axis component (EdnrA, EdnrB, ET-1, ET-3) expression in developing extramedullary hematopoietic organs and that some splenic B lymphocytes express EdnrB. Splenic B lymphocytes from EdnrBNCC-/- mice showed no intrinsic defect in survival vs. wild-type (WT) B lymphocytes. In vitro stimulation of splenic B lymphocytes demonstrated decreased IgA, IgG, and IgM production in EdnrBNCC-/- vs. WT mice. Additionally, small intestinal pIgR was decreased ∼50% in EdnrBNCC-/- mice. These results suggest an intrinsic B-lymphocyte defect in antibody production as well as an extrinsic defect in IgA transport in the EdnrBNCC-/- model of HAEC. Our results are consistent with human HAEC observations of decreased luminal sIgA and mouse models of other inflammatory bowel diseases, in which decreased pIgR is seen in concert with a dysregulated microbiota. Finally, our results suggest targeting the dysbiotic microbiome and pIgR-mediated sIgA transport as potential therapeutic approaches in prevention and treatment of HAEC.-Medrano, G., Cailleux, F., Guan, P., Kuruvilla, K., Barlow-Anacker, A. J., Gosain, A. B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulinA production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis.

Entities:  

Keywords:  IgA; aganglionosis; megacolon; mucosal immunity; polymeric Ig receptor

Mesh:

Substances:

Year:  2019        PMID: 30908942      PMCID: PMC6529339          DOI: 10.1096/fj.201801913R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.

Authors:  S H Murch; C P Braegger; W C Sessa; T T MacDonald
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

2.  Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease.

Authors:  Christoph Anthoni; Rudolf B Mennigen; Emile J M Rijcken; Mike G Laukötter; Hans-Ullrich Spiegel; Norbert Senninger; Guido Schürmann; Christian F Krieglstein
Journal:  Int J Colorectal Dis       Date:  2005-08-09       Impact factor: 2.571

3.  Role of endothelins on lymphocyte accumulation in allergic pleurisy.

Authors:  A L Sampaio; G A Rae; M M Henriques
Journal:  J Leukoc Biol       Date:  2000-02       Impact factor: 4.962

4.  Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung's disease.

Authors:  A Imamura; P Puri; D S O'Briain; D J Reen
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut.

Authors:  Keiichiro Suzuki; Bob Meek; Yasuko Doi; Masamichi Muramatsu; Tsutomu Chiba; Tasuku Honjo; Sidonia Fagarasan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

6.  The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors.

Authors:  Hyung-Ok Lee; John M Levorse; Myung K Shin
Journal:  Dev Biol       Date:  2003-07-01       Impact factor: 3.582

Review 7.  Innate immunity and toll-like receptors: clinical implications of basic science research.

Authors:  Maria T Abreu; Moshe Arditi
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

8.  Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops.

Authors:  Georgi Guruli; Beth R Pflug; Stefana Pecher; Valeria Makarenkova; Michael R Shurin; Joel B Nelson
Journal:  Blood       Date:  2004-06-22       Impact factor: 22.113

9.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements.

Authors:  Andreas Schroeder; Odilo Mueller; Susanne Stocker; Ruediger Salowsky; Michael Leiber; Marcus Gassmann; Samar Lightfoot; Wolfram Menzel; Martin Granzow; Thomas Ragg
Journal:  BMC Mol Biol       Date:  2006-01-31       Impact factor: 2.946

10.  Innate secretory antibodies protect against natural Salmonella typhimurium infection.

Authors:  Odilia L C Wijburg; Tania K Uren; Kim Simpfendorfer; Finn-Eirik Johansen; Per Brandtzaeg; Richard A Strugnell
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

View more
  2 in total

Review 1.  Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment.

Authors:  Ruth A Lewit; Korah P Kuruvilla; Ming Fu; Ankush Gosain
Journal:  Semin Pediatr Surg       Date:  2022-04-08       Impact factor: 1.900

2.  Cholinergic Signaling Attenuates Pro-Inflammatory Interleukin-8 Response in Colonic Epithelial Cells.

Authors:  Isabelle Müller; Urs Kym; Virginie Galati; Sasha Tharakan; Ulrike Subotic; Thomas Krebs; Eleuthere Stathopoulos; Peter Schmittenbecher; Dietmar Cholewa; Philipp Romero; Bertram Reingruber; Stefan Holland-Cunz; Simone Keck
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.